{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:15:36Z","timestamp":1783041336476,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50258-y","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:55:11Z","timestamp":1777881311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vitro antileishmanial evaluation, molecular docking, dynamics simulations, and DFT Studies of tetrahydropyridine derivatives as potential trypanothione reductase inhibitors"],"prefix":"10.1038","volume":"16","author":[{"given":"Elaheh","family":"Ataollahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Hatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"poustforoosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazi","family":"Dastkhosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefe","family":"Omidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Solhjoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soghra","family":"Khabnadideh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"issue":"40","key":"50258_CR1","first-page":"471","volume":"98","author":"JA Ruiz-Postigo","year":"2023","unstructured":"Ruiz-Postigo, J. A. et al. Global leishmaniasis surveillance, 2022: assessing trends over the past 10 years\/Surveillance mondiale de la leishmaniose, 2022: evaluation des tendances des 10 dernieres annees. Wkly Epidemiol. Rec. 98 (40), 471\u2013488 (2023).","journal-title":"Wkly Epidemiol. Rec."},{"issue":"35","key":"50258_CR2","first-page":"401","volume":"96","author":"JA Ruiz-Postigo","year":"2021","unstructured":"Ruiz-Postigo, J. A. et al. Global leishmaniasis surveillance: 2019\u20132020, a baseline for the 2030 roadmap\/Surveillance mondiale de la leishmaniose: 2019\u20132020, une periode de reference pour la feuille de route a l\u2019horizon 2030. Wkly Epidemiol. Rec. 96 (35), 401\u2013420 (2021).","journal-title":"Wkly Epidemiol. Rec."},{"issue":"2","key":"50258_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","volume":"8","author":"S Mann","year":"2021","unstructured":"Mann, S. et al. A review of leishmaniasis: Current knowledge and future directions. Curr. Trop. Med. Rep. 8(2), 121\u2013132 (2021).","journal-title":"Curr. Trop. Med. Rep."},{"key":"50258_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1052478","volume":"13","author":"CA Knight","year":"2023","unstructured":"Knight, C. A. et al. Leishmaniasis: Recent epidemiological studies in the Middle East. Front. Microbiol. 13, 1052478 (2023).","journal-title":"Front. Microbiol."},{"issue":"5","key":"50258_CR5","doi-asserted-by":"publisher","first-page":"e0285520","DOI":"10.1371\/journal.pone.0285520","volume":"18","author":"A Spotin","year":"2023","unstructured":"Spotin, A., Rouhani, S., Haghighi, A. & Parvizi, P. Low genetic heterogeneity of Leishmania major in different geographical regions of Iran. PLoS. One 18(5), e0285520 (2023).","journal-title":"PLoS. One"},{"issue":"1","key":"50258_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/pathogens12010039","volume":"12","author":"AA Rabaan","year":"2022","unstructured":"Rabaan, A. A. et al. Omics approaches in drug development against leishmaniasis: Current scenario and future prospects. Pathogens 12 (1), 39 (2022).","journal-title":"Pathogens"},{"issue":"1","key":"50258_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","volume":"9","author":"S Srivastava","year":"2016","unstructured":"Srivastava, S., Shankar, P., Mishra, J. & Singh, S. Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit. Vectors 9(1), 277 (2016).","journal-title":"Parasit. Vectors"},{"issue":"8","key":"50258_CR8","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3390\/molecules25081924","volume":"25","author":"T Battista","year":"2020","unstructured":"Battista, T., Colotti, G., Ilari, A. & Fiorillo, A. Targeting trypanothione reductase, a key enzyme in the redox trypanosomatid metabolism, to develop new drugs against leishmaniasis and trypanosomiases. Molecules 25 (8), 1924 (2020).","journal-title":"Molecules"},{"issue":"8","key":"50258_CR9","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3390\/ph18081182","volume":"18","author":"A Augusto","year":"2025","unstructured":"Augusto, A., Costa, I., Concei\u00e7\u00e3o, J. & Cristiano, M. L. Targeting Trypanothione Synthetase and Trypanothione Reductase: Development of Common Inhibitors to Tackle Trypanosomatid Disease. Pharmaceuticals 18 (8), 1182 (2025).","journal-title":"Pharmaceuticals"},{"issue":"10","key":"50258_CR10","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3390\/molecules29102214","volume":"29","author":"M-C Gonz\u00e1lez-Montero","year":"2024","unstructured":"Gonz\u00e1lez-Montero, M-C. et al. Targeting trypanothione metabolism in trypanosomatids. Molecules 29 (10), 2214 (2024).","journal-title":"Molecules"},{"issue":"15","key":"50258_CR11","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2174\/1381612826666201211115329","volume":"27","author":"MD Pi\u00f1eyro","year":"2021","unstructured":"Pi\u00f1eyro, M. D., Arias, D., Parodi-Talice, A., Guerrero, S. & Robello, C. Trypanothione metabolism as drug target for trypanosomatids. Curr. Pharm. Design. 27 (15), 1834\u20131846 (2021).","journal-title":"Curr. Pharm. Design"},{"issue":"7","key":"50258_CR12","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1007\/s42250-024-00944-z","volume":"7","author":"B Nehra","year":"2024","unstructured":"Nehra, B., Kumar, M., Singh, S., Chawla, V. & Chawla, P. A. Sojourn of Nitrogenous Heterocycles as Promising Antileishmanial Agents: Medicinal Perspectives and Structure\u2013Activity Relationship Studies. Chem. Afr. 7 (7), 3485\u20133529 (2024).","journal-title":"Chem. Afr."},{"issue":"3","key":"50258_CR13","doi-asserted-by":"publisher","first-page":"e202402223","DOI":"10.1002\/cbdv.202402223","volume":"22","author":"R Mohan Malothu","year":"2025","unstructured":"Mohan Malothu, R. & Thalari, G. Design and synthesis of novel thiazole linked tetrahydropyridine analogues as anticancer agents. Chem. Biodivers. 22 (3), e202402223 (2025).","journal-title":"Chem. Biodivers."},{"key":"50258_CR14","doi-asserted-by":"publisher","first-page":"107674","DOI":"10.1016\/j.bioorg.2024.107674","volume":"151","author":"G Sharma","year":"2024","unstructured":"Sharma, G. & Sharma, C. Tetrahydropyridine appended 8-aminoquinoline derivatives: Design, synthesis, in silico, and in vitro antimalarial studies. Bioorg. Chem. 151, 107674 (2024).","journal-title":"Bioorg. Chem."},{"issue":"3","key":"50258_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/md22030126","volume":"22","author":"S Fern\u00e1ndez","year":"2024","unstructured":"Fern\u00e1ndez, S., Arn\u00e1iz, V., Rufo, D. & Arroyo, Y. Current status of indole-derived marine natural products: synthetic approaches and therapeutic applications. Mar. Drugs. 22 (3), 126 (2024).","journal-title":"Mar. Drugs"},{"issue":"8","key":"50258_CR16","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/17460441.2025.2530589","volume":"20","author":"G Visbal","year":"2025","unstructured":"Visbal, G. & Navarro, M. Designing drugs against leishmaniasis: Is targeting the sterol biosynthesis pathway the answer?. Expert Opin. Drug Discov. 20(8), 1031\u20131044 (2025).","journal-title":"Expert Opin. Drug Discov."},{"issue":"21","key":"50258_CR17","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.2174\/1568026621666210303144448","volume":"21","author":"PF da Silva Santos-J\u00fanior","year":"2021","unstructured":"da Silva Santos-J\u00fanior, P. F., Schmitt, M., de Ara\u00fajo-J\u00fanior, J. X. & da Silva-J\u00fanior, E. F. Sterol 14\u03b1-demethylase from trypanosomatidae parasites as a promising target for designing new antiparasitic agents. Curr. Top. Med. Chem. 21(21), 1900\u20131921 (2021).","journal-title":"Curr. Top. Med. Chem."},{"issue":"11","key":"50258_CR18","volume":"36","author":"L Mac\u00eado","year":"2025","unstructured":"Mac\u00eado, L. et al. Leishmania chagasi dihydrofolate reductase-thymidylate synthase potential inhibitors identified by virtual screening. J. Braz. Chem. Soc. 36(11), e\u201320250108 (2025).","journal-title":"J. Braz. Chem. Soc."},{"issue":"2","key":"50258_CR19","first-page":"222","volume":"7","author":"BBF Mirjalili","year":"2021","unstructured":"Mirjalili, B. B. F., Hoseinikhah, S. S., Salehi, N. & Bamoniri, A. An affordable and eco-friendly method for pseudo-five-component synthesis of tetrahydropyridines using Gum Arabic-OPO3H2 as a natural-based catalyst. Org. Chem. Res. 7(2), 222\u2013230 (2021).","journal-title":"Org. Chem. Res."},{"issue":"1","key":"50258_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202401300","volume":"22","author":"TA Oliveira","year":"2025","unstructured":"Oliveira, T. A. et al. Antibacterial and antileishmanial activity of 1, 4-dihydropyridine derivatives. Chem. Biodivers. 22(1), e202401300 (2025).","journal-title":"Chem. Biodivers."},{"issue":"14","key":"50258_CR21","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1016\/j.bmc.2008.05.074","volume":"16","author":"BC Galarreta","year":"2008","unstructured":"Galarreta, B. C. et al. The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors. Bioorg. Med. Chem. 16(14), 6689\u20136695 (2008).","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"50258_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11686-021-00457-6","volume":"67","author":"B Jeddi","year":"2022","unstructured":"Jeddi, B., Saberi, S., Men\u00e9ndez, J. C. & Sepehri, S. Synthesis and biological evaluation of tetrahydropyrimidine and dihydropyridine derivatives against Leishmania major. Acta Parasitol. 67(1), 255\u2013266 (2022).","journal-title":"Acta Parasitol."},{"issue":"1","key":"50258_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012735","volume":"19","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Progress in antileishmanial drugs: Mechanisms, challenges, and prospects. PLoS Negl. Trop. Dis. 19(1), e0012735 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"11","key":"50258_CR24","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2174\/0115680266323908241114064318","volume":"25","author":"CD Sri","year":"2025","unstructured":"Sri, C. D. et al. Updates on intrinsic medicinal chemistry of 1, 4-dihydropyridines, perspectives on synthesis and pharmacokinetics of novel 1, 4-dihydropyrimidines as calcium channel blockers: Clinical pharmacology. Curr. Top. Med. Chem. 25(11), 1351\u20131376 (2025).","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"50258_CR25","doi-asserted-by":"publisher","first-page":"e13812","DOI":"10.1016\/j.heliyon.2023.e13812","volume":"9","author":"H Tsuruga","year":"2023","unstructured":"Tsuruga, H., Murata, H., Araie, M. & Aihara, M. Neuroprotective effect of the calcium channel blocker nilvadipine on retinal ganglion cell death in a mouse ocular hypertension model. Heliyon 9(3), e13812. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13812 (2023).","journal-title":"Heliyon"},{"key":"50258_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11030-018-9839-y","volume":"22","author":"L Kang","year":"2018","unstructured":"Kang, L. et al. Structure\u2013activity relationship investigation of coumarin\u2013chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Mol. Divers. 22, 893\u2013906 (2018).","journal-title":"Mol. Divers."},{"key":"50258_CR27","doi-asserted-by":"crossref","unstructured":"Poustforoosh, A. & Elyasi, M. Leveraging scaffold hopping and machine learning for the innovative design and assessment of pyridine derivatives as c-Met inhibitors using amide-based bioisosteres. J. Comput. Biophys. Chem. 25(11), 2309\u20132323 (2025).","DOI":"10.1142\/S2737416526500110"},{"issue":"1","key":"50258_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s40203-025-00541-z","volume":"14","author":"Z Maravandi","year":"2026","unstructured":"Maravandi, Z., Gholamian, S., Samadi, A. & Gross, J. D. In silico evaluation of procyanidin as a potential ESR1 inhibitor: Docking and MD insights in uterine fibroids and endometriosis. In Silico Pharmacol. 14(1), 29 (2026).","journal-title":"In Silico Pharmacol."},{"key":"50258_CR29","doi-asserted-by":"crossref","unstructured":"Poustforoosh, A. Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy. Mol. Divers. 29(4), 3293\u20133303 (2025).","DOI":"10.1007\/s11030-025-11114-9"},{"key":"50258_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/adts.202501220","author":"A Poustforoosh","year":"2025","unstructured":"Poustforoosh, A., Sepahi, S. & Elyasi, M. Innovative design and assessment of dual-targeted c-Met\/PARP1 inhibitors using Pyridine-2-amine bioisosteres: Scaffold hopping, machine learning, molecular docking, molecular dynamics, and ADME\/T analysis. Adv. Theory Simul. 8(12), e01220 (2025).","journal-title":"Adv. Theory Simul."},{"issue":"10","key":"50258_CR31","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1007\/s12033-024-01307-2","volume":"67","author":"A Poustforoosh","year":"2025","unstructured":"Poustforoosh, A. Scaffold hopping method for design and development of potential allosteric AKT inhibitors. Mol. Biotechnol. 67(10), 3960\u20133974 (2025).","journal-title":"Mol. Biotechnol."},{"issue":"6","key":"50258_CR32","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/jat.4768","volume":"45","author":"B Guo","year":"2025","unstructured":"Guo, B. & He, X. The mechanism of Bisphenol S-induced atherosclerosis elucidated based on network toxicology, molecular docking, and machine learning. J. Appl. Toxicol. 45(6), 1043\u20131055 (2025).","journal-title":"J. Appl. Toxicol."},{"key":"50258_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138331","volume":"1308","author":"Z Yan","year":"2024","unstructured":"Yan, Z. et al. Synthesis, bioactivity evaluation and theoretical study of nicotinamide derivatives containing diphenyl ether fragments as potential succinate dehydrogenase inhibitors. J. Mol. Struct. 1308, 138331 (2024).","journal-title":"J. Mol. Struct."},{"key":"50258_CR34","doi-asserted-by":"crossref","unstructured":"Zare, H., Rahbarnia, L., Pazhang, M. & Salahlou, R. Rational design of a novel anti-cancer hybrid peptide inhibiting the PI3K\/AKT and CDK2 signaling pathways using molecular dynamics simulations. Probiotics Antimicrob. Proteins 1\u201318 (2026).","DOI":"10.1007\/s12602-025-10904-9"},{"issue":"27","key":"50258_CR35","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1002\/jcc.26012","volume":"40","author":"V Choudhary","year":"2019","unstructured":"Choudhary, V., Bhatt, A., Dash, D. & Sharma, N. DFT calculations on molecular structures, HOMO\u2013LUMO study, reactivity descriptors and spectral analyses of newly synthesized diorganotin (IV) 2-chloridophenylacetohydroxamate complexes. J. Comput. Chem. 40 (27), 2354\u20132363 (2019).","journal-title":"J. Comput. Chem."},{"issue":"1\u20132","key":"50258_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/1747519820932091","volume":"45","author":"M Miar","year":"2021","unstructured":"Miar, M., Shiroudi, A., Pourshamsian, K., Oliaey, A. R. & Hatamjafari, F. Theoretical investigations on the HOMO\u2013LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3-phenylbenzo [d] thiazole-2 (3 H)-imine and its para-substituted derivatives: Solvent and substituent effects. J. Chem. Res. 45(1\u20132), 147\u2013158 (2021).","journal-title":"J. Chem. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50258-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50258-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50258-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:21:01Z","timestamp":1783038061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50258-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50258"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50258-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study utilized commercially available cell lines (Leishmania major promastigotes (strain MRHO\/IR\/75\/ER)) obtained from the National Cell Bank of Iran (NCBI), and no human or animal subjects were directly involved. All experimental protocols followed standard guidelines for in vitro research, and no additional consent procedures were necessary.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20482"}}